PF-06804103 Dose Escalation in HER2 Positive and Negative (Negative Only in Part 2) Solid Tumors
Status: COMPLETED
Study type: INTERVENTIONAL
Conditions: Breast Neoplasms
Interventions: DRUG: PF-06804103|DRUG: PF-06804103 + Palbociclib +Letrozole
Sponsor: Pfizer